The Torg-Pavlov ratio in cervical spondylotic myelopathy - A comparative study between patients with cervical spondylotic myelopathy and nonspondylotic, nonmyelopathic population
Wm. Yue et al., The Torg-Pavlov ratio in cervical spondylotic myelopathy - A comparative study between patients with cervical spondylotic myelopathy and nonspondylotic, nonmyelopathic population, SPINE, 26(16), 2001, pp. 1760-1764
Study Design. A radiologic study to compare the Torg-Pavlov ratios between
patients with cervical spondylotic myelopathy and a nonspondylotic, nonmyel
opathic population.
Objectives. To determine and compare the Torg-Pavlov ratios between the two
groups of patients.
Summary of Background Data. Patients with congenital cervical spinal canal
stenosis are more likely to develop cervical spondylotic myelopathy. The To
rg-Pavlov ratio eliminates errors related to magnification, a problem with
determination of spinal canal stenosis from direct measurements of plain ce
rvical spine radiographs. There has only been one other study that directly
compares the Torg-Pavlov ratio between patients with cervical spondylotic
myelopathy and a normal control population.
Methods. The preoperative plain lateral cervical spine radiographs of 28 pa
tients with cervical spondylotic myelopathy requiring surgical decompressio
n were compared with radiographs of 88 nonspondylotic, nonmyelopathic patie
nts. The Torg-Pavlov ratio was computed for each level from C3 to C7.
Results. The study showed that the Torg-Pavlov ratio is significantly small
er (P < 0.001) in myelopathic patients (mean 0.72 +/- 0.08) compared with t
he control patients (mean 0.95 +/- 0.14). This was so when individual level
s and the mean values were compared. Age was also found to be a significant
factor (P = 0.002), although lesser in magnitude when compared with the To
rg-Pavlov ratio (P = 0.0001).
Conclusions. The Torg-Pavlov ratio is significantly lower in patients with
cervical spondylotic myelopathy compared with a nonspondylotic, nonmyelopat
hic population. It could possibly be used to predict the likelihood of deve
loping cervical spondylotic myelopathy.